Centene Co. (NYSE:CNC – Get Rating) – Equities researchers at Oppenheimer issued their FY2025 EPS estimates for Centene in a report issued on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn anticipates that the company will post earnings per share of $8.15 for the year. The consensus estimate for Centene's current full-year earnings is $5.72 per share.
Get
Centene alerts:
Centene (NYSE:CNC – Get Rating) last released its quarterly earnings data on Tuesday, October 25th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.08. Centene had a net margin of 1.42% and a return on equity of 13.08%. The business had revenue of $35.84 billion for the quarter, compared to analyst estimates of $35.45 billion. During the same quarter last year, the firm earned $1.26 EPS. Centene's quarterly revenue was up 10.6% compared to the same quarter last year.
Several other brokerages also recently commented on CNC. StockNews.com upgraded shares of Centene from a "buy" rating to a "strong-buy" rating in a report on Monday, January 16th. Bank of America downgraded shares of Centene from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $100.00 to $85.00 in a report on Tuesday, December 13th. Barclays dropped their target price on shares of Centene from $107.00 to $100.00 and set an "overweight" rating on the stock in a report on Monday, October 3rd. JPMorgan Chase & Co. dropped their target price on shares of Centene from $103.00 to $98.00 and set an "overweight" rating on the stock in a report on Friday, January 6th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Centene from $99.00 to $94.00 in a report on Wednesday, October 26th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $101.35.
Centene Stock Down 0.0 %
Centene stock opened at $75.76 on Monday. The company's 50 day simple moving average is $81.37 and its 200 day simple moving average is $84.56. Centene has a fifty-two week low of $73.19 and a fifty-two week high of $98.53. The firm has a market capitalization of $42.90 billion, a price-to-earnings ratio of 22.09, a PEG ratio of 0.90 and a beta of 0.60. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.06 and a quick ratio of 1.06.
Centene announced that its Board of Directors has initiated a share buyback plan on Friday, December 16th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the company to reacquire up to 4.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its stock is undervalued.
Hedge Funds Weigh In On Centene
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Chilton Capital Management LLC bought a new position in Centene during the second quarter worth $25,000. Fieldpoint Private Securities LLC boosted its position in Centene by 112.0% during the second quarter. Fieldpoint Private Securities LLC now owns 335 shares of the company's stock worth $28,000 after purchasing an additional 177 shares during the period. Crewe Advisors LLC bought a new stake in shares of Centene in the second quarter valued at about $31,000. Larson Financial Group LLC boosted its position in shares of Centene by 30.1% in the second quarter. Larson Financial Group LLC now owns 592 shares of the company's stock valued at $50,000 after acquiring an additional 137 shares during the period. Finally, CoreCap Advisors LLC bought a new stake in shares of Centene in the second quarter valued at about $51,000. 93.28% of the stock is owned by institutional investors.
Centene Company Profile
(Get Rating)
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.
Recommended Stories
- Get a free copy of the StockNews.com research report on Centene (CNC)
- EVgo Stock is Charged Up to Ride the EV Adoption Wave
- Qualcomm Gets a Boost from Analysts, but is it Time to Buy?
- High-Yield, Deep-Value Verizon Puts In A Bottom
- Should You Bet Against The Nasdaq 100 With This Inverse ETF?
- Can Coty Stock Emerge in 2023 With Upside
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
